{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:02:12Z","timestamp":1782590532290,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01541-9","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T04:10:12Z","timestamp":1738037412000},"page":"4763-4773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Kia Ann Sean","family":"Phang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0980-9936","authenticated-orcid":false,"given":"Chin Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"1541_CR1","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1186\/1471-2202-9-S2-S16","volume":"9","author":"LC Costantini","year":"2008","unstructured":"Costantini LC, Barr LJ, Vogel JL, Henderson ST. Hypometabolism as a therapeutic target in Alzheimer\u2019s disease. BMC Neurosci. 2008;9:S16.","journal-title":"BMC Neurosci"},{"key":"1541_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32.","journal-title":"Mol Neurodegener"},{"key":"1541_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.tics.2013.08.007","volume":"17","author":"MN Braskie","year":"2013","unstructured":"Braskie MN, Thompson PM. Understanding cognitive deficits in Alzheimer\u2019s disease based on neuroimaging findings. Trends Cogn Sci. 2013;17:510\u20136.","journal-title":"Trends Cogn Sci"},{"key":"1541_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12:357\u201367.","journal-title":"Lancet Neurol"},{"key":"1541_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s43587-023-00404-2","volume":"3","author":"WM van der Flier","year":"2023","unstructured":"van der Flier WM, de Vugt ME, Smets EMA, Blom M, Teunissen CE. Towards a future where Alzheimer\u2019s disease pathology is stopped before the onset of dementia. Nature Aging. 2023;3:494\u2013505.","journal-title":"Nature Aging"},{"key":"1541_CR6","first-page":"47","volume":"4","author":"ED Anderson","year":"2016","unstructured":"Anderson ED, Wahoske M, Huber M, Norton D, Li Z, Koscik RL, Umucu E, Johnson SC, Jones J, Asthana S, Gleason CE, AsDN I. Cognitive variability\u2014a marker for incident MCI and AD: an analysis for the Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheim Dement: Diagn Assess Dis Monit. 2016;4:47\u201355.","journal-title":"Alzheim Dement: Diagn Assess Dis Monit"},{"key":"1541_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/gps.2738","volume":"27","author":"SF Carter","year":"2012","unstructured":"Carter SF, Caine D, Burns A, Herholz K, Lambon Ralph MA. Staging of the cognitive decline in Alzheimer\u2019s disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2012;27:423\u201332.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1541_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-170498","volume":"61","author":"CE Gleason","year":"2018","unstructured":"Gleason CE, Norton D, Anderson ED, Wahoske M, Washington DT, Umucu E, Koscik RL, Dowling NM, Johnson SC, Carlsson CM, Asthana S. Cognitive variability predicts incident Alzheimer\u2019s disease and mild cognitive impairment comparable to a cerebrospinal fluid biomarker. J Alzheimers Dis. 2018;61:79\u201389.","journal-title":"J Alzheimers Dis"},{"key":"1541_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1037\/neu0000867","volume":"37","author":"BM Scott","year":"2023","unstructured":"Scott BM, Austin T, Royall DR, Hilsabeck RC. Cognitive intraindividual variability as a potential biomarker for early detection of cognitive and functional decline. Neuropsychology. 2023;37:52\u201363.","journal-title":"Neuropsychology"},{"key":"1541_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1037\/neu0000532","volume":"33","author":"KJ Bangen","year":"2019","unstructured":"Bangen KJ, Weigand AJ, Thomas KR, Delano-Wood L, Clark LR, Eppig J, Werhane ML, Edmonds EC, Bondi MW. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults. Neuropsychology. 2019;33:599\u2013608.","journal-title":"Neuropsychology"},{"key":"1541_CR11","doi-asserted-by":"publisher","first-page":"859873","DOI":"10.3389\/fnagi.2022.859873","volume":"14","author":"SL Holmqvist","year":"2022","unstructured":"Holmqvist SL, Thomas KR, Brenner EK, Edmonds EC, Calcetas A, Edwards L, Bordyug M, Bangen KJ. Longitudinal intraindividual cognitive variability is associated with reduction in regional cerebral blood flow among Alzheimer\u2019s disease biomarker-positive older adults. Front Aging Neurosci. 2022;14:859873.","journal-title":"Front Aging Neurosci"},{"key":"1541_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/jama.300.7.823","volume":"300","author":"R Holtzer","year":"2008","unstructured":"Holtzer R, Verghese J, Wang C, Hall CB, Lipton RB. Within-person across-neuropsychological test variability and incident dementia. JAMA. 2008;300:823\u201330.","journal-title":"JAMA"},{"key":"1541_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968\u201380.","journal-title":"Neuroimage"},{"key":"1541_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ana.23908","volume":"74","author":"SM Landau","year":"2013","unstructured":"Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid. Ann Neurol. 2013;74:826\u201336.","journal-title":"Ann Neurol"},{"key":"1541_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ. PET imaging of Tau deposition in the aging human brain. Neuron. 2016;89:971\u201382.","journal-title":"Neuron"},{"key":"1541_CR16","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/hbm.23922","volume":"39","author":"M Belathur Suresh","year":"2018","unstructured":"Belathur Suresh M, Fischl B, Salat DH. Factors influencing accuracy of cortical thickness in the diagnosis of Alzheimer\u2019s disease. Hum Brain Mapp. 2018;39:1500\u201315.","journal-title":"Hum Brain Mapp"},{"key":"1541_CR17","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97:11050\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1541_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging. 2011;32:1207\u201318.","journal-title":"Neurobiol Aging"},{"key":"1541_CR19","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1212\/WNL.0000000000011214","volume":"96","author":"ME Farrell","year":"2021","unstructured":"Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, Jacobs HIL, Hanseeuw BJ, Rentz DM, Villemagne VL, Papp KV, Mormino EC, Betensky RA, Johnson KA, Sperling RA, Buckley RF. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology. 2021;96:e619\u201331.","journal-title":"Neurology"},{"key":"1541_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-022-00986-w","volume":"14","author":"AJ Weigand","year":"2022","unstructured":"Weigand AJ, Maass A, Eglit GL, Bondi MW. What\u2019s the cut-point?: a systematic investigation of tau PET thresholding methods. Alzheimers Res Ther. 2022;14:49.","journal-title":"Alzheimers Res Ther"},{"key":"1541_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/brain\/awy327","volume":"142","author":"CH Tan","year":"2019","unstructured":"Tan CH, Bonham LW, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL, Yaffe K, Schellenberg GD, Kauppi K, Holland D, McEvoy LK, Kukull WA, Tosun D, Weiner MW, Sperling RA, Bennett DA, Hyman BT, Andreassen OA, Dale AM, Desikan RS, Initiative ftAsDN,. Polygenic hazard score, amyloid deposition and Alzheimer\u2019s neurodegeneration. Brain. 2019;142:460\u201370.","journal-title":"Brain"},{"key":"1541_CR22","doi-asserted-by":"publisher","first-page":"132037","DOI":"10.1016\/j.ijcard.2024.132037","volume":"407","author":"CH Tan","year":"2024","unstructured":"Tan CH, Tan JJX. Associations of cardiac function and arterial stiffness with cerebrovascular disease. Int J Cardiol. 2024;407:132037.","journal-title":"Int J Cardiol"},{"issue":"10","key":"1541_CR23","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1093\/brain\/awaa248","volume":"143","author":"CR Jack","year":"2020","unstructured":"Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Ferman TJ, Boeve BF, Kantarci K, Vemuri P, Mielke MM, Whitwell J, Josephs K, Schwarz CG, Senjem ML, Gunter JL, Petersen RC. Predicting future rates of tau accumulation on PET. Brain. 2020;143(10):3136\u201350.","journal-title":"Brain"},{"key":"1541_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","volume":"73","author":"WJ Jagust","year":"2009","unstructured":"Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA. Relationships between biomarkers in aging and dementia. Neurology. 2009;73:1193\u20139.","journal-title":"Neurology"},{"key":"1541_CR25","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91:e859\u201366.","journal-title":"Neurology"},{"key":"1541_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, Huijbers W, Hedden T, Marshall GA, Chhatwal JP, Rentz DM, Sperling RA, Johnson K. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76:915\u201324.","journal-title":"JAMA Neurol"},{"key":"1541_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2967\/jnumed.121.263694","volume":"63","author":"M Malpetti","year":"2022","unstructured":"Malpetti M, Joie R, Rabinovici GD. Tau beats amyloid in predicting brain atrophy in Alzheimer disease: implications for prognosis and clinical trials. J Nucl Med. 2022;63:830\u20132.","journal-title":"J Nucl Med"},{"key":"1541_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","volume":"78","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, Palmqvist S, Olsson T, J\u00f6gi J, Stormrud E, Cho H, Ryu YH, Choi JY, Boxer AL, Gorno-Tempini ML, Miller BL, Soleimani-Meigooni D, Iaccarino L, La Joie R, Baker S, Borroni E, Klein G, Pontecorvo MJ, Devous MD Sr, Jagust WJ, Lyoo CH, Rabinovici GD, Hansson O. Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol. 2021;78:961\u201371.","journal-title":"JAMA Neurol"},{"key":"1541_CR29","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, F\u00f6rster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, G\u00f3mez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, K\u00f6hler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lle\u00f3 A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendon\u00e7a A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, M\u00f8llerg\u00e5rd HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodr\u00edguez-Rodr\u00edguez E, Roe CM, Rot U, Rowe CC, R\u00fcther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schr\u00f6der J, Sch\u00fctte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, Van Waalwijk van Doorn LJ, Waldemar G, Wallin A, Wallin \u00c5K, Wiltfang J, Wolk DA, Zboch M, Zetterberg H. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 2015;313:1924\u201338.","journal-title":"Jama"},{"key":"1541_CR30","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1093\/brain\/awae116","volume":"147","author":"KA Cody","year":"2024","unstructured":"Cody KA, Langhough RE, Zammit MD, Clark L, Chin N, Christian BT, Betthauser TJ, Johnson SC. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer\u2019s disease. Brain. 2024;147:2144\u201357.","journal-title":"Brain"},{"key":"1541_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, Hanseeuw BJ, Buckley R, Chhatwal J, Hedden T, Marshall GA, Quiroz YT, Donovan NJ, Jackson J, Gatchel JR, Rabin JS, Jacobs H, Yang HS, Properzi M, Kirn DR, Rentz DM, Johnson KA. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85:181\u201393.","journal-title":"Ann Neurol"},{"key":"1541_CR32","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O\u2019Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140:3286\u2013300.","journal-title":"Brain"},{"key":"1541_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.nicl.2017.09.016","volume":"17","author":"L Iaccarino","year":"2018","unstructured":"Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O\u2019Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer\u2019s disease. Neuroimage Clin. 2018;17:452\u201364.","journal-title":"Neuroimage Clin"},{"key":"1541_CR34","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/acn3.339","volume":"3","author":"GN Bischof","year":"2016","unstructured":"Bischof GN, Jessen F, Fliessbach K, Dronse J, Hammes J, Neumaier B, Onur O, Fink GR, Kukolja J, Drzezga A, van Eimeren T. Impact of tau and amyloid burden on glucose metabolism in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2016;3:934\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"1541_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/alz.13355","volume":"20","author":"C Boccalini","year":"2024","unstructured":"Boccalini C, Ribaldi F, Hristovska I, Arnone A, Peretti DE, Mu L, Scheffler M, Perani D, Frisoni GB, Garibotto V. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimers Dement. 2024;20:221\u201333.","journal-title":"Alzheimers Dement"},{"key":"1541_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2967\/jnumed.119.235879","volume":"61","author":"E Fantoni","year":"2020","unstructured":"Fantoni E, Collij L, Lopes Alves I, Buckley C, Farrar G. The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging. J Nucl Med. 2020;61:166\u201371.","journal-title":"J Nucl Med"},{"key":"1541_CR37","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","volume":"89","author":"MJ Grothe","year":"2017","unstructured":"Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ. In vivo staging of regional amyloid deposition. Neurology. 2017;89:2031\u20138.","journal-title":"Neurology"},{"key":"1541_CR38","doi-asserted-by":"publisher","first-page":"fcaa007","DOI":"10.1093\/braincomms\/fcaa007","volume":"2","author":"PS Insel","year":"2020","unstructured":"Insel PS, Mormino EC, Aisen PS, Thompson WK, Donohue MC. Neuroanatomical spread of amyloid \u03b2 and tau in Alzheimer\u2019s disease: implications for primary prevention. Brain Commun. 2020;2:fcaa007.","journal-title":"Brain Commun"},{"key":"1541_CR39","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1523\/JNEUROSCI.0949-21.2021","volume":"42","author":"R de Flores","year":"2022","unstructured":"de Flores R, Das SR, Xie L, Wisse LEM, Lyu X, Shah P, Yushkevich PA, Wolk DA. Medial temporal lobe networks in Alzheimer\u2019s disease: structural and molecular vulnerabilities. J Neurosci. 2022;42:2131\u201341.","journal-title":"J Neurosci"},{"key":"1541_CR40","doi-asserted-by":"publisher","first-page":"eabc0655","DOI":"10.1126\/scitranslmed.abc0655","volume":"13","author":"JS Sanchez","year":"2021","unstructured":"Sanchez JS, Becker JA, Jacobs HIL, Hanseeuw BJ, Jiang S, Schultz AP, Properzi MJ, Katz SR, Beiser A, Satizabal CL, O\u2019Donnell A, DeCarli C, Killiany R, El Fakhri G, Normandin MD, G\u00f3mez-Isla T, Quiroz YT, Rentz DM, Sperling RA, Seshadri S, Augustinack J, Price JC, Johnson KA. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer\u2019s disease assessed with positron emission tomography. Sci Transl Med. 2021;13:eabc0655.","journal-title":"Sci Transl Med"},{"key":"1541_CR41","doi-asserted-by":"publisher","first-page":"e1512","DOI":"10.1212\/WNL.0000000000200137","volume":"98","author":"ME Farrell","year":"2022","unstructured":"Farrell ME, Papp KV, Buckley RF, Jacobs HIL, Schultz AP, Properzi MJ, Vannini P, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA. Association of emerging \u03b2-amyloid and tau pathology with early cognitive changes in clinically normal older adults. Neurology. 2022;98:e1512\u201324.","journal-title":"Neurology"},{"issue":"8","key":"1541_CR42","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/alz.12509","volume":"18","author":"JC Lennon","year":"2022","unstructured":"Lennon JC, Aita SL, Bene VAD, Rhoads T, Resch ZJ, Eloi JM, Walker KA. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement. 2022;18(8):1461\u201371.","journal-title":"Alzheimers Dement"},{"key":"1541_CR43","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3233\/JAD-190866","volume":"73","author":"CH Tan","year":"2020","unstructured":"Tan CH, Hilal S, Xu X, Vrooman H, Cheng CY, Wong TY, Venketasubramanian N, Chen C. MRI markers of mixed pathology and cognitive impairment in multiethnic Asians. J Alzheimers Dis. 2020;73:1501\u20139.","journal-title":"J Alzheimers Dis"},{"key":"1541_CR44","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s11357-023-00780-y","volume":"45","author":"CH Tan","year":"2023","unstructured":"Tan CH, Tan JJX. Low neighborhood deprivation buffers against hippocampal neurodegeneration, white matter hyperintensities, and poorer cognition. GeroScience. 2023;45:2027\u201336.","journal-title":"GeroScience"},{"key":"1541_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2022.03.013","volume":"115","author":"CH Tan","year":"2022","unstructured":"Tan CH, Chew J, Zhang L, Guly\u00e1s B, Chen C. Differential effects of white matter hyperintensities and regional amyloid deposition on regional cortical thickness. Neurobiol Aging. 2022;115:12\u20139.","journal-title":"Neurobiol Aging"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01541-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01541-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01541-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T14:01:58Z","timestamp":1750514518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01541-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01541-9","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This research study was conducted retrospectively from data obtained by ADNI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}